We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$53.7B
AUM Growth
-$2.95B
Cap. Flow
+$168M
Cap. Flow %
0.31%
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 31.44%
2 Financials 12.06%
3 Healthcare 11.81%
4 Communication Services 9.87%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QXO
451
QXO Inc
QXO
$14.6B
$8.04M 0.02%
413,949
-57,272
-12% -$1.31M
BCAX
452
Bicara Therapeutics
BCAX
$1.82B
$7.98M 0.01%
401,444
NAMS icon
453
NewAmsterdam Pharma
NAMS
$3.73B
$7.98M 0.01%
249,190
-300,321
-55% -$9.78M
FITB
454
Fifth Third Bancorp
FITB
$52.3B
$7.97M 0.01%
171,575
+114,221
+199% +$5.63M
RY icon
455
Royal Bank of Canada
RY
$294B
$7.91M 0.01%
49,081
-9,000
-15% -$1.51M
CCL icon
456
Carnival Corporation Ltd
CCL
$36.1B
$7.9M 0.01%
305,290
+77,080
+34% +$2.25M
DINO icon
457
HF Sinclair
DINO
$16.4B
$7.68M 0.01%
123,064
-29,507
-19% -$1.6M
NUE icon
458
Nucor
NUE
$53.7B
$7.66M 0.01%
45,283
+7,485
+20% +$1.3M
ELDN icon
459
Eledon Pharmaceuticals
ELDN
$293M
$7.59M 0.01%
2,464,919
TMDX icon
460
Transmedics
TMDX
$2.47B
$7.51M 0.01%
75,569
-5,034
-6% -$657K
LYV icon
461
Live Nation Entertainment
LYV
$41.7B
$7.51M 0.01%
49,213
-4,306
-8% -$652K
SYRE icon
462
Spyre Therapeutics
SYRE
$8.68B
$7.49M 0.01%
+148,537
New +$5.6M
EXEL icon
463
Exelixis
EXEL
$13.9B
$7.47M 0.01%
174,146
-9,463
-5% -$407K
AWK icon
464
American Water Works
AWK
$26.1B
$7.46M 0.01%
54,786
-35,056
-39% -$4.63M
TOST icon
465
Toast
TOST
$17.1B
$7.43M 0.01%
280,434
+44,022
+19% +$1.31M
DPZ icon
466
Domino's
DPZ
$10.6B
$7.39M 0.01%
20,610
+3,880
+23% +$1.53M
SYF icon
467
Synchrony
SYF
$24.5B
$7.38M 0.01%
108,559
+27,629
+34% +$2.01M
Q
468
Qnity Electronics Inc
Q
$29B
$7.29M 0.01%
63,223
+3,298
+6% +$350K
WSM icon
469
Williams-Sonoma
WSM
$26.2B
$7.24M 0.01%
39,688
-3,752
-9% -$749K
SAIL
470
SailPoint Inc
SAIL
$8.18B
$7.2M 0.01%
+543,980
New +$8.49M
WST icon
471
West Pharmaceutical
WST
$25.3B
$7.12M 0.01%
28,409
-61,328
-68% -$15.3M
ALLE icon
472
Allegion
ALLE
$12B
$7.04M 0.01%
48,449
+22,006
+83% +$3.51M
CPRT icon
473
Copart
CPRT
$25.1B
$7.03M 0.01%
211,747
-94,095
-31% -$3.54M
NTAP icon
474
NetApp
NTAP
$32.6B
$6.98M 0.01%
68,204
-1,324
-2% -$134K
ANAB icon
475
AnaptysBio
ANAB
$1.57B
$6.97M 0.01%
125,633
-89,821
-42% -$4.83M

Similar funds

Ensign Peak Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
  • Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
  • Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
  • Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
  • Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
  • Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.